Ph.D. Niro Ramachandran - 19 Nov 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role: Chief Business Officer
Signature: /s/ Niro Ramachandran, Ph.D., by Brian McKelligon, as Attorney-in-Fact
Issuer symbol: AKYA
Transactions as of: 19 Nov 2021
Net transactions value: +$329,231
Form type: 4
Filing time: 22 Nov 2021, 19:27:16 UTC
Next filing: 25 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKYA	Common Stock	Purchase	$938	+73		$12.85	73	19 Nov 2021	Direct
transaction	AKYA	Common Stock	Purchase	$328,292	+25,000	+34247%	$13.13	25,073	22 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $12.94-$13.1699. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.